Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Gynecol Endocrinol

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    March 2019
  1. FIORELLI-ARAZAWA LR, Haddad JM, Nicola MH, Machado JJDS, et al
    Hormonal oral contraceptive influence on isolation, Characterization and cryopreservation of mesenchymal stem cells from menstrual fluid.
    Gynecol Endocrinol. 2019 Mar 5:1-7. doi: 10.1080/09513590.2019.1579788.
    PubMed     Text format     Abstract available


    February 2019
  2. BARRIGA P, Vanhauwaert P, Porcile A
    Hormonal contraception and risk of breast cancer: a critical look.
    Gynecol Endocrinol. 2019 Feb 26:1-3. doi: 10.1080/09513590.2019.1576610.
    PubMed     Text format     Abstract available


    January 2019
  3. EKENROS L, Backstrom T, Hirschberg AL, Friden C, et al
    Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives.
    Gynecol Endocrinol. 2019 Jan 22:1-5. doi: 10.1080/09513590.2018.1534097.
    PubMed     Text format     Abstract available


  4. LETE I, Doval JL, Perez-Campos E, Alonso MJ, et al
    Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
    Gynecol Endocrinol. 2019 Jan 7:1-4. doi: 10.1080/09513590.2018.1559286.
    PubMed     Text format     Abstract available


  5. PIVA I, Brusca F, Tassinati F, Bonipozzi S, et al
    Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant.
    Gynecol Endocrinol. 2019 Jan 2:1-7. doi: 10.1080/09513590.2018.1538343.
    PubMed     Text format     Abstract available


    December 2018
  6. SABINE R, Stephanie H, Ariane G, Thomas S, et al
    Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application.
    Gynecol Endocrinol. 2018 Dec 31:1-3. doi: 10.1080/09513590.2018.1531985.
    PubMed     Text format     Abstract available


    October 2018
  7. WANDRESEN G, Sgarbi F, Nisihara R
    Management of contraceptives and menstrual complaints in patients with Down syndrome.
    Gynecol Endocrinol. 2018 Oct 16:1-6. doi: 10.1080/09513590.2018.1501017.
    PubMed     Text format     Abstract available


  8. XU Z, Meng L, Pan C, Chen X, et al
    Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
    PubMed     Text format     Abstract available


    September 2018
  9. MIAO J, Yan Q, Wang L, Wang X, et al
    Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review.
    Gynecol Endocrinol. 2018;34:734-735.
    PubMed     Text format     Abstract available


    July 2018
  10. VUJOVIC S, Ivovic M, Tancic-Gajic M, Marina L, et al
    Endometrium receptivity in premature ovarian insufficiency - how to improve fertility rate and predict diseases?
    Gynecol Endocrinol. 2018 Jul 25:1-5. doi: 10.1080/09513590.2018.1490715.
    PubMed     Text format     Abstract available


    May 2018
  11. STUMPF MAM, Kluthcovsky ACGC, Okamoto JM, Schrut GCA, et al
    Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
    Gynecol Endocrinol. 2018 May 21:1-3. doi: 10.1080/09513590.2018.1473365.
    PubMed     Text format     Abstract available


  12. RODRIGUEZ-PURATA J, Devesa M, Parriego M, Pardos C, et al
    Linking back-to-back stimulation cycles with oral contraceptives or progestins in women undergoing embryo accumulation for preimplantation genetic testing, a retrospective study.
    Gynecol Endocrinol. 2018 May 17:1-6. doi: 10.1080/09513590.2018.1473363.
    PubMed     Text format     Abstract available


  13. FULGHESU AM, Melis F, Murru G, Canu E, et al
    Very low dose of flutamide in the treatment of hyperandrogenism.
    Gynecol Endocrinol. 2018;34:394-398.
    PubMed     Text format     Abstract available


    April 2018
  14. MANIGLIO P, Ricciardi E, Meli F, Tomao F, et al
    Complete remission of cerebral endometriosis with dienogest: a case report.
    Gynecol Endocrinol. 2018 Apr 20:1-3. doi: 10.1080/09513590.2018.1463362.
    PubMed     Text format     Abstract available


  15. ALTINOK ML, Ravn P, Andersen M, Glintborg D, et al
    Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
    Gynecol Endocrinol. 2018 Apr 16:1-5. doi: 10.1080/09513590.2018.1460343.
    PubMed     Text format     Abstract available


    January 2018
  16. BRICHANT G, Nervo P, Albert A, Munaut C, et al
    Heterogeneity of estrogen receptor alpha and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.
    Gynecol Endocrinol. 2018 Jan 31:1-5. doi: 10.1080/09513590.2018.1433160.
    PubMed     Text format     Abstract available


  17. HERSHKO KLEMENT A, Frederic M, Bentov Y, Chang P, et al
    Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Gynecol Endocrinol. 2018 Jan 18:1-3. doi: 10.1080/09513590.2018.1427714.
    PubMed     Text format     Abstract available


  18. MORGANTE G, Massaro MG, Di Sabatino A, Cappelli V, et al
    Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Gynecol Endocrinol. 2018;34:4-9.
    PubMed     Text format     Abstract available


    December 2017
  19. ESTADELLA J, Espanol P, Ascencio F, Perello J, et al
    Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.
    Gynecol Endocrinol. 2017 Dec 20:1-4. doi: 10.1080/09513590.2017.1417376.
    PubMed     Text format     Abstract available


  20. NERI M, Piras B, Paoletti AM, Vallerino V, et al
    Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women.
    Gynecol Endocrinol. 2017 Dec 19:1-4. doi: 10.1080/09513590.2017.1416465.
    PubMed     Text format     Abstract available


    November 2017
  21. MABROUK M, Paradisi R, Arena A, Del Forno S, et al
    Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecol Endocrinol. 2017 Nov 21:1-5. doi: 10.1080/09513590.2017.1405932.
    PubMed     Text format     Abstract available


    October 2017
  22. JIN P, Xie Y
    Treatment strategies for women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Oct 31:1-6. doi: 10.1080/09513590.2017.1395841.
    PubMed     Text format     Abstract available


    September 2017
  23. SZUBERT M, Zietara M, Suzin J
    Conservative treatment of deep infiltrating endometriosis: review of existing options.
    Gynecol Endocrinol. 2017 Sep 27:1-5. doi: 10.1080/09513590.2017.1381837.
    PubMed     Text format     Abstract available


  24. BALDANI DP, Skrgatic L, Ougouag R, Kasum M, et al
    The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Gynecol Endocrinol. 2017 Sep 23:1-5. doi: 10.1080/09513590.2017.1381681.
    PubMed     Text format     Abstract available


  25. MODAFFARI P, D'alonzo M, Garbagnati M, Pecchio S, et al
    Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
    Gynecol Endocrinol. 2017 Sep 21:1-3. doi: 10.1080/09513590.2017.1380186.
    PubMed     Text format     Abstract available


    June 2017
  26. KIM SW, Kim H, Ku SY, Suh CS, et al
    A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecol Endocrinol. 2017 Jun 26:1-5. doi: 10.1080/09513590.2017.1342239.
    PubMed     Text format     Abstract available


  27. SABBIONI L, Petraglia F, Luisi S
    Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
    Gynecol Endocrinol. 2017 Jun 6:1-8. doi: 10.1080/09513590.2017.1334198.
    PubMed     Text format     Abstract available


    May 2017
  28. NERI M, Malune ME, Corda V, Piras B, et al
    Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Gynecol Endocrinol. 2017 May 9:1-5. doi: 10.1080/09513590.2017.1322574.
    PubMed     Text format     Abstract available


    April 2017
  29. BAS-LANDO M, Rabinowitz R, Farkash R, Algur N, et al
    Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320376.
    PubMed     Text format     Abstract available


  30. KEBAPCILAR AG, Ilhan TT, Dursunoglu D, Kebapcilar L, et al
    Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1320384.
    PubMed     Text format     Abstract available


  31. MOROTTI E, Casadio P, Guasina F, Battaglia B, et al
    Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Gynecol Endocrinol. 2017 Apr 17:1-5. doi: 10.1080/09513590.2017.1306850.
    PubMed     Text format     Abstract available


  32. GRANDI G, Mueller MD, Bersinger NA, Facchinetti F, et al
    The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1314458.
    PubMed     Text format     Abstract available


    March 2017
  33. SANT'ANNA GD, Brum IS, Branchini G, Pizzolato LS, et al
    Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1301924.
    PubMed     Text format     Abstract available


  34. TANMAHASAMUT P, Saejong R, Rattanachaiyanont M, Angsuwathana S, et al
    Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 7:1-6. doi: 10.1080/09513590.2017.1296124.
    PubMed     Text format     Abstract available


    January 2017
  35. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Text format     Abstract available


  36. MULLER V, Kogan I, Yarmolinskaya M, Niauri D, et al
    Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecol Endocrinol. 2017;33.
    PubMed     Text format     Abstract available


    December 2016
  37. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  38. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  39. SHARIFZADEH F, Aminimoghaddam S, Kashanian M, Fazaeli M, et al
    A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  40. SEIKKULA J, Anttila L, Polo-Kantola P, Bloigu R, et al
    Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  41. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Text format     Abstract available


  42. DAKHLY DM, Bayoumi YA, Gad Allah SH
    Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.
    Gynecol Endocrinol. 2016;32:116-9.
    PubMed     Text format     Abstract available


  43. PAOLETTI AM, Lello S, Di Carlo C, Orru M, et al
    Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
    Gynecol Endocrinol. 2016;32:61-4.
    PubMed     Text format     Abstract available


  44. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Text format     Abstract available


    December 2015
  45. SAITO F, Tashiro H, Yamaguchi M, Honda R, et al
    Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  46. POLYZOS NP, Corona R, Van De Vijver A, Blockeel C, et al
    Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: